IndraLab
Statements
sparser
"Crucially, we identified a specific interaction between Talin2 and OTUB1, enabling a novel precision therapeutic strategy: targeted small‐molecule inhibitors designed to disrupt Talin2/OTUB1 binding affinity. [ xref ] This approach achieves dual therapeutic effects by accelerating Talin2 degradation, blocking mechano‐inflammatory signal conversion, and promoting ECM synthesis."